These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 3164256)

  • 41. A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.
    Guadagni F; Ferroni P; Carlini S; Mariotti S; Spila A; Aloe S; D'Alessandro R; Carone MD; Cicchetti A; Ricciotti A; Venturo I; Perri P; Di Filippo F; Cognetti F; Botti C; Roselli M
    Clin Cancer Res; 2001 Aug; 7(8):2357-62. PubMed ID: 11489813
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge as an adjunct in the diagnosis of early breast cancer. Research Group for Carcinoembryonic Antigen in Nipple Discharge.
    Mori T; Inaji H; Higashiyama M; Yayoi E; Izuo M; Ueno E; Enomoto K; Kasumi F; Sakamoto G; Tominaga T
    Jpn J Clin Oncol; 1989 Dec; 19(4):373-9. PubMed ID: 2691732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Carcinoembryonic antigens (CEA) in patients with metastatic breast cancer under endocrine and therapeutic treatment (author's transl)].
    Pompecki R; Schröder G; Garbrecht M; Frahm H
    Dtsch Med Wochenschr; 1978 Apr; 103(14):620-2. PubMed ID: 639696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The usefulness of CA15.3, mucin-like carcinoma-associated antigen and carcinoembryonic antigen in determining the clinical course in patients with metastatic breast cancer.
    Deprés-Brummer P; Itzhaki M; Bakker PJ; Hoek FJ; Veenhof KH; de Wit R
    J Cancer Res Clin Oncol; 1995; 121(7):419-22. PubMed ID: 7635872
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.
    Nicolini A; Colombini C; Luciani L; Carpi A; Giuliani L
    Br J Cancer; 1991 Jul; 64(1):154-8. PubMed ID: 1854615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carcinoembryonic antigen in patients with breast or colon cancer.
    Lee YN
    West J Med; 1978 Nov; 129(5):374-80. PubMed ID: 364839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic value of cancer antigen 15-3 (CA15-3) detected by monoclonal antibodies (115D8 and DF3) in exudative pleural effusions.
    Shimokata K; Totani Y; Nakanishi K; Yamamoto M; Hasegawa Y; Kawatsu H; Sasou H; Murate T; Ichiyama S; Kurasawa T
    Eur Respir J; 1988 Apr; 1(4):341-4. PubMed ID: 3165069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Tumor marker: practical usage of tumor marker for recurrent breast cancer--our experience].
    Yoshimoto M
    Gan To Kagaku Ryoho; 1990 Nov; 17(11):2277-83. PubMed ID: 2241194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccination with a mixed vaccine of autogenous and allogeneic breast cancer cells and tumor associated antigens CA15-3, CEA and CA125--results in immune and clinical responses in breast cancer patients.
    Jiang XP; Yang DC; Elliott RL; Head JF
    Cancer Biother Radiopharm; 2000 Oct; 15(5):495-505. PubMed ID: 11155821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients.
    Zeiwar MM; Zaki SM; Mohammad LA; Zidan AA; El Nagar MR
    Egypt J Immunol; 2007; 14(2):29-41. PubMed ID: 20306655
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [CA15-3 tumor marker in early detection of breast cancer].
    Roisman I; Shiloni E; Lifshiz I; Shoshani D; Saphir D; Honigman I; Livni N; Sherman Y; Papo O; Durst AL
    Harefuah; 1992 Feb; 122(4):213-8. PubMed ID: 1563679
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Leukocyte alkaline phosphatase and carcinoembryonic antigen in breast cancer patients. Influence of the treatment on the markers.
    Walach N; Guterman A; Zaidman JL; Scharf S; Weinberger L; Kaufman S
    Neoplasma; 1990; 37(6):627-30. PubMed ID: 2274082
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence for the elevation of serum carcinoembryonic antigen and tumor-associated glycoprotein-72 levels in patients administered interferons.
    Greiner JW; Guadagni F; Goldstein D; Borden EC; Ritts RE; Witt P; LoBuglio AF; Saleh MN; Schlom J
    Cancer Res; 1991 Aug; 51(16):4155-63. PubMed ID: 1907881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Carcinoembryonic antigen (CEA) in patients with lung cancer: correlation with tumour extent and response to treatment (author's transl)].
    Gropp C; Lehmann FG; Havemann K
    Dtsch Med Wochenschr; 1977 Jul; 102(30):1079-82. PubMed ID: 891388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carcinoembryonic antigen, ferritin, tissue polypeptide antigen, and CA15/3 in breast cancer: relationship between carcinoma and normal breast tissue.
    Gion M; Mione R; Dittadi R; Griggio L; Munegato G; Valsecchi M; Del Maschio O; Bruscagnin G
    Int J Biol Markers; 1986; 1(1):33-8. PubMed ID: 3480322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum protein-bound carbohydrates for following the course of disease in patients with metastatic breast carcinoma.
    Waalkes TP; Mrochek JE; Dinsmore SR; Tormey DC
    J Natl Cancer Inst; 1978 Sep; 61(3):703-7. PubMed ID: 278847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma carcinoembryonic antigen in an Australian hospital population.
    Frost MA; Coates AS
    Med J Aust; 1976 Jun; 1(25):950-3. PubMed ID: 979758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies.
    Perrier A; Boelle PY; Chrétien Y; Gligorov J; Lotz JP; Brault D; Comperat E; Lefèvre G; Boissan M
    PLoS One; 2020; 15(1):e0227356. PubMed ID: 31910438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of relationship between parity and level of carcinoembryonic antigen in women with breast cancer.
    Heller R; Fisher R; Nash A; Knapp J
    Anticancer Res; 1990; 10(6):1755-7. PubMed ID: 2285254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Evaluation of plasma carcinoembryonic antigen (CEA) in patients with head and neck cancer: correlation with tissue CEA staining].
    Kawasaki T; Nagamine T; Suzuki I; Shingaki S; Nakajima T; Suzuki M
    Gan No Rinsho; 1986 Feb; 32(2):133-40. PubMed ID: 2421023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.